Evidence map›Paper›PMID 38679674›Full record

ReviewLasers in medical science2024

Definition of refractory melasma and its treatment: a review.

Huiyi Yao, Sihao Shen, Xingyue Gao, Jiangfeng Feng, Xiuzu Song, Wenzhong Xiang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Lasers in medical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Huiyi YaoDepartment of Dermatology, Zhejiang Chinese Medical University, Hangzhou Third People's Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
Sihao ShenDepartment of Dermatology, Zhejiang Chinese Medical University, Hangzhou Third People's Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
Xingyue GaoDepartment of Dermatology, Zhejiang Chinese Medical University, Hangzhou Third People's Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
Jiangfeng FengDepartment of Dermatology, Zhejiang Chinese Medical University, Hangzhou Third People's Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
Xiuzu SongDepartment of Dermatology, Hangzhou Third People's Hospital, Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
Wenzhong XiangDepartment of Dermatology, Hangzhou Third People's Hospital, Affiliated to Zhejiang Chinese Medical University, Hangzhou, China. xiangwenzhong@126.com.ORCID http://orcid.org/0000-0003-3619-7741

Funding

Hangzhou biomedical and health industry development support project 2021WJCY159Hangzhou medical key discipline construction project No [37]21-3
6 · The paper itself

Abstract

Although patients with refractory melasma have been treated using various methods, there is still no precise definition or summary of the therapies. To define refractory melasma and conduct a review of the treatments, we searched for relevant publications in PubMed, Web of Science, and the Cochrane Library, and a total of 35 references were obtained. Refractory melasma can be roughly defined as an ineffective treatment for melasma, including topical bleaching agents, chemical peels, laser therapy, microdermabrasion for more than six months, or chemical peels treated more than six times. Meanwhile, physicians should be careful when treating patients with darker skin and dermal or mixed types of melasma since these individuals do not respond well to treatment. Lasers combined with other methods, especially different types of lasers or topical agents, are considered more effective than monotherapy. Oral tranexamic acid (TXA) is a prospective cure for refractory melasma. Other methods include a combination of chemical peels, microneedling, or injections with additional therapies. In conclusion, we were able to provide a rough definition of refractory melasma and list the available therapies. According to the literature, the most prevalent treatment is laser combination therapy. However, laser treatment should be considered only after topical agents and chemical peeling have failed. Considering its side effects, efficacy, and safety, oral TXA may be a better option, but more research is needed to make a firm conclusion. Moreover, maintenance therapy is required after treatment.

Indexed as

ChemexfoliationMelanosisCombined Modality TherapyDermabrasionHumansLaser TherapyLow-Level Light TherapyTranexamic AcidTranexamic AcidDefinitionLaserOral TXARefractory melasmaReviewTreatment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.